Milton Werner News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Milton werner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Milton Werner Today - Breaking & Trending Today

Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Q1 2024 Earnings Call Transcript

Operator: Greetings and welcome to Inhibikase Therapeutics First Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode. ....

Red White , Alexander Lobo , Garth Lees Rolfe , Milton Werner , Inhibikase Therapeutics Inc , National Institutes Of Health , National Institute Of Neurological Disease , Division Of Cardiology , Office Of Cardiology , National Cancer Institute , Inhibikase Therapeutics , Call Transcript May , Inhibikase Therapeutics First Quarter , Results Conference , Stern Investor , Chief Executive Officer , Chief Financial , Safe Harbor Provisions , Private Securities Litigation Reform Act , National Institute , Neurological Disease , National Institutes , Chief Financial Officer ,

Inhibikase Therapeutics Announces Final Pre-IND Meeting Outcomes for IkT-001Pro as a Treatment for Pulmonary Arterial Hypertension

Inhibikase Therapeutics Announces Final Pre-IND Meeting Outcomes for IkT-001Pro as a Treatment for Pulmonary Arterial Hypertension
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United States , Miltonh Werner , Milton Werner , Alex Lobo , Company Phase , Division Of Cardiology , Inhibikase Therapeutics Inc , Exchange Commission , Stern Investor Relations Inc , Company Contact , Inhibikase Or Company , Drug Administration , New Molecular Entity , Pulmonary Arterial Hypertension , Abelson Tyrosine Kinases , Investigational New Drug , Chief Executive Officer , Pulmonary Arterial , Arterial Hypertension , Abelson Tyrosine Kinase , Abelson Tyrosine , Multiple System Atrophy , Private Securities Litigation Reform Act , Investor Relations ,

Inhibikase Therapeutics Announces Pre-IND Meeting with the FDA for IkT-001Pro in Pulmonary Arterial Hypertension

Meeting to discuss potential of IkT-001Pro as a disease modifying treatment for Pulmonary Arterial HypertensionBOSTON and ATLANTA, April 03, 2024 Inhibikase Therapeutics, Inc. , a. ....

United States , Alex Lobo , Miltonh Werner , Milton Werner , Inhibikase Therapeutics Inc , Drug Administration , Stern Investor Relations Inc , Office Of Cardiology , Division Of Cardiology , Inhibikase Or Company , Exchange Commission , Company Contact , Pulmonary Arterial , Abelson Tyrosine Kinases , Pulmonary Arterial Hypertension , Chief Executive Officer , Arterial Hypertension , Abelson Tyrosine Kinase , Abelson Tyrosine , Multiple System Atrophy , Private Securities Litigation Reform Act , Investor Relations ,

Inhibikase Therapeutics (IKT) Announces Pre-IND Meeting with the FDA for IkT-001Pro in Pulmonary Arterial Hypertension

Inhibikase Therapeutics (IKT) Announces Pre-IND Meeting with the FDA for IkT-001Pro in Pulmonary Arterial Hypertension
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Milton Werner , Drug Administration , Inhibikase Therapeutics Inc , Inhibikase Or Company , Division Of Cardiology , Office Of Cardiology , Inhibikase Therapeutics , Abelson Tyrosine Kinases , Pulmonary Arterial Hypertension , Chief Executive Officer , Arterial Hypertension ,

Inhibikase Announces Pre-IND Meeting For IkT-001Pro

Inhibikase Therapeutics, Inc. (IKT) announced it will meet with the Office of Cardiology, Hematology, Endocrinology and Nephrology in the Division of Cardiology and Nephrology at the FDA for a Pre-IND meeting to discuss IkT-001Pro as a treatment for Pulmonary Arterial Hypertension. ....

Milton Werner , More Such Health News , Inhibikase Therapeutics Inc , Division Of Cardiology , Office Of Cardiology , Inhibikase Therapeutics , Pulmonary Arterial , Pulmonary Arterial Hypertension ,